MR-proADM as prognostic factor of outcome in COVID-19 patients
Abstract Mid Regional pro-ADM (MR-proADM) is a promising novel biomarker in the evaluation of deteriorating patients and an emergent prognosis factor in patients with sepsis, septic shock and organ failure. It can be induced by bacteria, fungi or viruses. We hypothesized that the assessment of MR-pr...
Main Authors: | Emanuela Sozio, Carlo Tascini, Martina Fabris, Federica D’Aurizio, Chiara De Carlo, Elena Graziano, Flavio Bassi, Francesco Sbrana, Andrea Ripoli, Alberto Pagotto, Alessandro Giacinta, Valentina Gerussi, Daniela Visentini, Paola De Stefanis, Maria Merelli, Kordo Saeed, Francesco Curcio |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-84478-1 |
Similar Items
-
Mr-proADM and MR-proANP levels in patients with acute pulmonary embolism
by: Öner Önsel, et al.
Published: (2020-01-01) -
Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM
by: Cornelia Then, et al.
Published: (2016-09-01) -
Application of MR-ProADM to predict prevention of hospitalisation, derived from a multi-centre study
by: Milo Cullinan, et al.
Published: (2019-04-01) -
Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
by: Uğur Önal, et al.
Published: (2018-09-01) -
Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
by: Luis García de Guadiana-Romualdo, et al.
Published: (2021-10-01)